Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles.

We have used a systematic methodology to tailor the in vitro drug release profiles for a system of PLGA/PLA nanoparticles encapsulating a hydrophobic drug, haloperidol. We applied our previously developed sonication and homogenization methods to produce haloperidol-loaded PLGA/PLA nanoparticles with 200-1000 nm diameters and 0.2-2.5% drug content. The three important properties affecting release behavior were identified as: polymer hydrophobicity, particle size and particle coating. Increasing the polymer hydrophobicity reduces the initial burst and extends the period of release. Increasing the particle size reduces the initial burst and increases the rate of release. It was also shown that coating the particles with chitosan significantly reduces the initial burst without affecting other parts of the release profile. Various combinations of the above three properties were used to achieve in vitro release of drug over a period of 8, 25 and >40 days, with initial burst <25% and a steady release rate over the entire period of release. Polymer molecular weight and particle drug content were inconsequential for drug release in this system. Experimental in vitro drug release data were fitted with available mathematical models in literature to establish that the mechanism of drug release is predominantly diffusion controlled. The average value of drug diffusivities for PLGA and PLA nanoparticles was calculated and its variation with particle size was established.

[1]  Ge Jiang,et al.  Preparation and Characterization of a Composite PLGA and Poly(Acryloyl Hydroxyethyl Starch) Microsphere System for Protein Delivery , 2001, Pharmaceutical Research.

[2]  T. Kissel,et al.  Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems , 1992 .

[3]  Juergen Siepmann,et al.  How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. , 2005, Biomacromolecules.

[4]  Y. Youn,et al.  Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Ilia Fishbein,et al.  Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Panos Macheras,et al.  Analysis of Case II drug transport with radial and axial release from cylinders. , 2003, International journal of pharmaceutics.

[7]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[8]  S. Feng,et al.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[9]  R. Gurny,et al.  In Vitro Extended-Release Properties of Drug-Loaded Poly(DL-Lactic Acid) Nanoparticles Produced by a Salting-Out Procedure , 1993, Pharmaceutical Research.

[10]  Xun Sun,et al.  Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo , 2006, Journal of materials science. Materials in medicine.

[11]  Ilia Fishbein,et al.  Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[12]  S. Siegel,et al.  Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol , 2005, Journal of microencapsulation.

[13]  A. Durand,et al.  Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres , 2003 .

[14]  K. Avgoustakis,et al.  Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. , 2004, Current drug delivery.

[15]  A. Karydas,et al.  PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  S. Siegel,et al.  Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. , 2007, International journal of pharmaceutics.

[17]  Cory Berkland,et al.  Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Indu Bala,et al.  PLGA nanoparticles in drug delivery: the state of the art. , 2004, Critical reviews in therapeutic drug carrier systems.

[20]  Hatem Fessi,et al.  In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities , 1996 .

[21]  Tae Gwan Park,et al.  Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight , 1994 .

[22]  T. Chung,et al.  Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. , 2001, Journal of microencapsulation.

[23]  G. Barratt,et al.  Colloidal drug carriers: achievements and perspectives , 2003, Cellular and Molecular Life Sciences CMLS.

[24]  T. Chung,et al.  A method using biodegradable polylactides/polyethylene glycol for drug release with reduced initial burst. , 1999, International journal of pharmaceutics.

[25]  S. Feng,et al.  Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. , 2003, Biomaterials.

[26]  J. Feijen,et al.  In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[27]  P. Deluca,et al.  Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  R. Bodmeier,et al.  The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .

[29]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[30]  T. Park,et al.  Poly(L-lactic acid)/pluronic blends : characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrices , 1992 .

[31]  T Görner,et al.  Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.